Prof Marta Boffito, MD, PhD, FRCP, MBA is a consultant physician and the Clinical Director of HIV, Sexual and Gender Health, Dermatology at Chelsea and Westminster Hospital and is academically affiliated to Imperial College London, London, UK.

She trained in Italy, the USA, and the UK and has a special interest in antiviral drug pharmacology: from prevention to treatment. She runs numerous research projects and clinical trials (including COVID-19, flu, HIV, TB vaccines and treatments).

She consults on complex pharmacological issues, sees patients with HIV (she founded the first HIV over-50-years clinic in London, UK), and teaches HIV medicine, infectious diseases and pharmacology at Imperial College and in various National and International settings, including the Middle East and North Africa (MENA) region, where she has established some training initiatives on the management of people living with HIV.

She contributes to the educational, scientific, and guideline-formulation activities of national and international bodies including the British HIV Association (BHIVA), the World Health Organisation (WHO), and UNICEF (Eastern Europe and Central Asia). She has been involved in capacity building programmes for resource-limited settings (e.g., Uganda) and is an applicant on numerous successful collaborative international grants. She has published over 200 peer-reviewed articles, editorials, and reviews.

Bio

Bio

Philip Goulder is a Professor of Immunology at the University of Oxford in UK. He read Zoology at Oxford University and then Medicine at Cambridge University before specialising in Paediatrics. His research centres on mechanisms of immune control of HIV infection in children and adults, on defining the mechanisms by which paediatric HIV cure can be achieved, and on the impact of early life immune sex differences on paediatric cure potential. An additional aspect of this work is the evolutionary impact of the HIV epidemic: specifically, immune-driven selection and evolution of HIV, and HIV-driven selection and evolution of humans. Based at the Peter Medawar Building in Oxford, this work is focused on the HIV epidemic in South Africa through long-term links in Kimberley and in Durban with the Doris Duke Medical Research Institute at the University of Kwa-Zulu-Natal, CAPRISA and the African Health Research Institute (AHRI). In addition, this work is also supported by long-standing collaborations with colleagues at the Ragon Institute of MGH, MIT and Harvard in Boston where Goulder is a Research Associate.

Bio

Prof Sharon Lewin
Director – The Peter Doherty Institute for Infection and Immunity
Director – The Cumming Global Centre for Pandemic Therapeutics

Prof Sharon Lewin is an infectious diseases physician and basic virologist, who is internationally renowned for her research into all aspects of HIV disease and specifically in strategies to achieve an HIV cure. She is a Melbourne Laureate Professor of Medicine at the University of Melbourne.

Sharon heads a laboratory working on basic and translational research and early phase clinical trials aimed at finding a cure for HIV, understanding how HIV interacts with hepatitis B and novel antiviral strategies for SARS-CoV2.

Goedele Maertens is a Professor in Retrovirology at Imperial College London, UK. She received her BSc in Chemistry and MSc in Biochemistry from the Katholieke Universiteit Leuven (KUL, Belgium). During her PhD in Biochemistry at the KUL, with two years training in the Engelman lab at Dana-Farber Cancer Institute/Harvard Medical School (Boston, MA), she investigated the interactions between HIV-1 integrase and its host factor LEDGF/p75. Following a four-year postdoctoral fellowship in Molecular Oncology at Cancer Research UK (London, UK) she joined the Cherepanov lab at Imperial College London where she trained in structural virology. Since 2011, Maertens runs her laboratory at Imperial College London. Her research interests include mechanisms and inhibition of retroviral integration with a particular focus on human T-cell lymphotropic virus. Since 2025 she is the Head of Section of Virology within the Department of Infectious Disease.

Bio

Bio

European Centre for Disease Prevention and Control (ECDC)
Expert Communicable Disease Prevention and Control

Teymur Noori works at the European Centre for Disease Prevention and Control (ECDC) and is primarily responsible for monitoring the HIV response in Europe and assessing how countries are progressing toward the Sustainable Development Goals for HIV.

Bio

Anton Pozniak e started caring for patients with HIV in 1983 in London.  In 1990 completed his doctorate on TB/HIV in Zimbabwe. He is Consultant Physician at the Chelsea and Westminster Hospital and was Director of the HIV service from 2008 until 2018. He was President of the International AIDS Society from 2018-2020 and was President, and now Executive member, of the European AIDS Trial Network NEAT-ID 2012 to present. He is Principal Investigator for a Test and Treat project in Tanzania, Guidelines panel member of WHO, the European AIDS Clinical Society and BHIVA.  He is a DSMB chair for MRC and PENTA studies.

Bio

Bio

André van de Ven

Medical education at Ghent University and Diploma Tropical Medicine and International Health at Leopold Institute Antwerp. Six years employment by Dutch and Botswana government as tropical doctor in Botswana, followed by specialization internal medicine and infectious diseases at Radboud University Medical Center Nijmegen, the Netherlands. Defended PhD thesis cum laude on side effects of cotrimoxazole in HIV infection at Radboud University.

Worked for five years as medical specialist and academic researcher at Maastricht University and thereafter at Radboudumc as head Infectious Diseases and professor International Health with special focus on research capacity building in low and middle income countries through translational studies on infectious diseases. Since 2019, Andre van der Ven, together with Mihai Netea, is coordinating the 2000HIV study, that applies a multi-omics approach and functional immunological assays to better understand HIV biology and its complications.